BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 29016353)

  • 1. Markers influencing the presence of partial clinical remission in patients with newly diagnosed type 1 diabetes.
    Pyziak A; Zmyslowska A; Bobeff K; Malachowska B; Fendler W; Wyka K; Baranowska-Jazwiecka A; Szymanska M; Szadkowska A; Mlynarski W
    J Pediatr Endocrinol Metab; 2017 Oct; 30(11):1147-1153. PubMed ID: 29016353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early weight gain after diagnosis may have an impact on remission status in children with new-onset type 1 diabetes mellitus.
    Emet DC; Karavar HN; Gozmen O; Agyar AA; Ünsal Y; Canturk M; Cengiz P; Vuralli D; Ozon ZA; Gonc EN
    J Diabetes; 2023 Dec; 15(12):1011-1019. PubMed ID: 37572062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial Clinical Remission Reduces Lipid-Based Cardiovascular Risk in Adult Patients With Type 1 Diabetes.
    Nwosu BU; Parajuli S; Khatri K; Jasmin G; Al-Halbouni L; Lee AF
    Front Endocrinol (Lausanne); 2021; 12():705565. PubMed ID: 34899592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A predictive model for lack of partial clinical remission in new-onset pediatric type 1 diabetes.
    Marino KR; Lundberg RL; Jasrotia A; Maranda LS; Thompson MJ; Barton BA; Alonso LC; Nwosu BU
    PLoS One; 2017; 12(5):e0176860. PubMed ID: 28459844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The remission phase in adolescents and young adults with newly diagnosed type 1 diabetes mellitus: prevalence, predicting factors and glycemic control during follow-up.
    Yazidi M; Mahjoubi S; Oueslati I; Chaker F; Chihaoui M
    Arch Endocrinol Metab; 2022 Apr; 66(2):222-228. PubMed ID: 35315990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in insulin sensitivity in the partial remission phase of childhood type 1 diabetes; a longitudinal cohort study.
    Mørk FCB; Madsen JOB; Jensen AK; Hall GV; Pilgaard KA; Pociot F; Johannesen J
    Diabet Med; 2022 Feb; 39(2):e14702. PubMed ID: 34564895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete remission in children and adolescents with type 1 diabetes mellitus-prevalence and factors.
    Podolakova K; Barak L; Jancova E; Tarnokova S; Podracka L; Dobiasova Z; Skopkova M; Gasperikova D; Stanik J
    Sci Rep; 2023 Apr; 13(1):6790. PubMed ID: 37100887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial clinical remission in type 1 diabetes: a comparison of the accuracy of total daily dose of insulin of <0.3 units/kg/day to the gold standard insulin-dose adjusted hemoglobin A1c of ≤9 for the detection of partial clinical remission.
    Lundberg RL; Marino KR; Jasrotia A; Maranda LS; Barton BA; Alonso LC; Nwosu BU
    J Pediatr Endocrinol Metab; 2017 Aug; 30(8):823-830. PubMed ID: 28753540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Children with type 1 diabetes who experienced a honeymoon phase had significantly lower LDL cholesterol 5 years after diagnosis.
    Nwosu BU; Zhang B; Ayyoub SS; Choi S; Villalobos-Ortiz TR; Alonso LC; Barton BA
    PLoS One; 2018; 13(5):e0196912. PubMed ID: 29768449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remission phase in children diagnosed with type 1 diabetes in years 2012 to 2013 in Silesia, Poland: An observational study.
    Chobot A; Stompór J; Szyda K; Sokołowska M; Deja G; Polańska J; Jarosz-Chobot P
    Pediatr Diabetes; 2019 May; 20(3):286-292. PubMed ID: 30714298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Theory of Hyperlipidemic Memory of Type 1 Diabetes.
    Nwosu BU
    Front Endocrinol (Lausanne); 2022; 13():819544. PubMed ID: 35432186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of remission and its duration on development of early microvascular complications in young adults with type 1 diabetes.
    Niedzwiecki P; Pilacinski S; Uruska A; Adamska A; Naskret D; Zozulinska-Ziolkiewicz D
    J Diabetes Complications; 2015; 29(8):1105-11. PubMed ID: 26427560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetuin-A and Interleukine-8 in Children with the Clinical Remission of Type 1 Diabetes.
    Pyziak-Skupien A; Bobeff K; Wyka K; Banach K; Malachowska B; Fendler W; Szadkowska A; Mlynarski W; Zmyslowska A
    Iran J Immunol; 2020 Jun; 17(2):144-153. PubMed ID: 32602468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms and early patterns of dyslipidemia in pediatric type 1 and type 2 diabetes.
    Nwosu BU; Villalobos-Ortiz TR; Jasmin GA; Parajuli S; Zitek-Morrison E; Barton BA
    J Pediatr Endocrinol Metab; 2020 Nov; 33(11):1399-1408. PubMed ID: 33027052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial remission in children and adolescents with type 1 diabetes: an analysis based on the insulin dose-adjusted hemoglobin A1c.
    Cimbek EA; Bozkır A; Usta D; Beyhun NE; Ökten A; Karagüzel G
    J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1311-1317. PubMed ID: 34271601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Age on Partial Clinical Remission among Children with Newly Diagnosed Type 1 Diabetes.
    Passanisi S; Salzano G; Gasbarro A; Urzì Brancati V; Mondio M; Pajno GB; Alibrandi A; Lombardo F
    Int J Environ Res Public Health; 2020 Jul; 17(13):. PubMed ID: 32635304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current use of metformin in addition to insulin in pediatric patients with type 1 diabetes mellitus: an analysis based on a large diabetes registry in Germany and Austria.
    Konrad K; Datz N; Engelsberger I; Grulich-Henn J; Hoertenhuber T; Knauth B; Meissner T; Wiegand S; Woelfle J; Holl RW;
    Pediatr Diabetes; 2015 Nov; 16(7):529-37. PubMed ID: 25131985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in weight and BMI following the diagnosis of type 1 diabetes in children and adolescents.
    de Vries L; Bar-Niv M; Lebenthal Y; Tenenbaum A; Shalitin S; Lazar L; Cohen A; Phillip M
    Acta Diabetol; 2014; 51(3):395-402. PubMed ID: 24158774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excessive BMI is associated with higher C-peptide level at recognition but also with its greater loss in two years clinical observation in children with new onset type 1 diabetes.
    Kurpiewska E; Ciężki S; Jamiołkowska-Sztabkowska M; Polkowska A; Starosz A; Grubczak K; Moniuszko M; Bossowski A; Głowińska-Olszewska B
    Front Immunol; 2023; 14():1176403. PubMed ID: 37180128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proinsulin, GLP-1, and glucagon are associated with partial remission in children and adolescents with newly diagnosed type 1 diabetes.
    Kaas A; Andersen ML; Fredheim S; Hougaard P; Buschard K; Petersen JS; de Beaufort C; Robertson KJ; Hansen L; Mortensen HB; Nielsen LB;
    Pediatr Diabetes; 2012 Feb; 13(1):51-8. PubMed ID: 22118630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.